WeiCheng Su

WeiCheng Su

Company: Exonox Biosciences

Job title: Chief Innovation Officer


Exosome- Based Therapeutical Solution from “Right” Targets 12:00 pm

Development of triple negative breast cancer specific biomarker panel from patients What spell the “right” biomarker(s) for potential metastasis/recurrence Plan to the confirmation of functional biomarkers leading to the druggable targetsRead more

day: Day 1 Track B - AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.